{
  "company": {
    "name": "Superluminal Medicines",
    "website": "https://superluminalrx.com/",
    "record": "https://startuphistory.org/c/superluminalrx.com"
  },
  "status": null,
  "history_since": null,
  "baseline": null,
  "live_captures": 0,
  "last_checked": null,
  "live_status": "blocked",
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Genesis Therapeutics",
      "record": "https://startuphistory.org/c/genesis.ml",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use AI generative chemistry platforms to design and validate novel small‑molecule therapeutics."
    },
    {
      "name": "Exscientia",
      "record": "https://startuphistory.org/c/exscientia.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both apply AI-driven drug discovery to design and optimize novel small-molecule drug candidates."
    },
    {
      "name": "PostEra",
      "record": "https://startuphistory.org/c/postera.ai",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both offer AI-powered medicinal chemistry platforms for accelerating small-molecule drug discovery."
    },
    {
      "name": "Valence Discovery",
      "record": "https://startuphistory.org/c/valencediscovery.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use AI-driven generative molecular design to discover and optimize small-molecule therapeutics."
    },
    {
      "name": "Variational AI",
      "record": "https://startuphistory.org/c/variational.ai",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both run AI generative platforms to create novel small molecules for early-stage drug discovery."
    },
    {
      "name": "PharmCADD",
      "record": "https://startuphistory.org/c/pharmcadd.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI and modeling of protein–ligand interactions to support small-molecule drug design."
    },
    {
      "name": "InterAx Biotech",
      "record": "https://startuphistory.org/c/interaxbiotech.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI and modeling to design and optimize drugs for GPCR or complex signaling targets."
    },
    {
      "name": "Anima Biotech",
      "record": "https://startuphistory.org/c/animabiotech.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI with experimental biology platforms to discover small-molecule modulators of disease targets."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Superluminal Medicines” company record, https://startuphistory.org/c/superluminalrx.com"
}